Intuitive Surgical

Current directors and officers who also hold a role at another S&P 500 company.

• Lewis ChewANET · DirectorCDNS · Director
• Amal M. JohnsonESS · Director
• Craig H. BarrattINTC · Director
• Jamie SamathKLAC · Director
• Sreelakshmi KolliZBH · Director

Latest Schedule 13D/13G filing per holder. Holders that reported falling below 5% are not shown. Index funds usually report once a year.

No 5% holder filings parsed yet for this company.

Open-market purchases and sales reported on Form 4. Grants, option exercises and tax withholding are excluded.

Every 8-K with Item 5.02 (departure, election or appointment of directors and officers). The text is the first paragraph of the item.

1. Nov 2, 2026

   On October 29, 2026, the Board of Directors (the “Board”) of Intuitive Surgical, Inc. (the “Company”) approved an increase in the size of the Board from ten to eleven members and appointed Aaron Martin to fill the resulting vacancy, effective as of January 1, 2027. Mr. Martin will not be appointed to any committees as of the effective date. The Board has determined that Mr. Martin is an independent director under applicable rules of the Nasdaq Stock Market (“Nasdaq”) and the U.S. Securities and Exchange Commission. Pursuant to the Company’s standard compensation program for its non-employee directors, Mr. Martin will receive an annual cash retainer of $70,000 for service as a member of the Board, which amount will be prorated for the portion of the fiscal year remaining following the effective date of his appointment. Mr.

   Read the 8-K filing
2. May 28, 2026

   Effective July 1, 2026, Henry L. Charlton will transition from his role as Chief Commercial and Marketing Officer of Intuitive Surgical, Inc. (the “Company”) and begin serving as Senior Vice President of Global Business Operations of the Company. Taylor Patton, Global Senior Vice President, Endoluminal will succeed Mr. Charlton as the Company’s Chief Commercial and Marketing Officer. A copy of the Company’s press release is included as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

   Read the 8-K filing
3. May 4, 2026

   Approval of the Amendment and Restatement of the Amended and Restated 2010 Incentive Award Plan The Board of Directors (the “Board”) of Intuitive Surgical, Inc. (the “Company”) previously adopted, subject to stockholder approval, the amendment and restatement of the Company’s Amended and Restated 2010 Incentive Award Plan (the “Amended 2010 Plan”), which (i) increases the number of shares of common stock reserved for issuance pursuant to awards granted under the Amended 2010 Plan from 120,350,000 to 125,350,000, (ii) extends the term of the Amended 2010 Plan to January 29, 2036, and (iii) further specifies the treatment of awards in connection with a change in control. At the Company’s annual meeting of stockholders held on April 30, 2026 (the “Annual Meeting”), the Company’s stockholders approved the Amended 2010 Plan.

   Read the 8-K filing
4. Dec 18, 2025

   Effective January 1, 2026, Brian E. Miller, Ph.D., will transition from his role as Chief Digital Officer of Intuitive Surgical, Inc. (the “Company”) and begin serving as Head of Digital and AI Strategy of the Company. In this role, Dr. Miller will no longer be reporting directly to the Company’s Chief Executive Officer.

   Read the 8-K filing
5. May 15, 2025

   On May 14, 2025, the Board of Directors (the “Board”) of Intuitive Surgical, Inc. (the “Company”) appointed David J. Rosa, currently the Company’s President, as Chief Executive Officer of the Company effective July 1, 2025. Mr. Rosa will replace Gary S. Guthart, Ph.D., who will step down as Chief Executive Officer of the Company effective July 1, 2025 and will assume the position of Executive Chair of the Board as of that same date, and will continue to serve as a director. In connection with Dr. Guthart’s appointment as Chair, the independent directors of the Board appointed Craig H. Barratt, Ph.D., the Board’s current Chair, to serve as the lead independent director of the Board also effective July 1, 2025. David J.

   Read the 8-K filing
6. May 5, 2025

   Approval of the Amendment and Restatement of the Amended and Restated 2010 Incentive Award Plan The Board of Directors (the “Board”) of Intuitive Surgical, Inc. (the “Company”) previously adopted, subject to stockholder approval, the amendment and restatement of the Company’s Amended and Restated 2010 Incentive Award Plan (the “Amended 2010 Plan”), which (i) increases the number of shares of common stock reserved for issuance pursuant to awards granted under the Amended 2010 Plan from 115,350,000 to 120,350,000, (ii) extends the term of the Amended 2010 Plan to January 30, 2035, and (iii) further specifies the treatment of awards in connection with a change in control. At the Company’s annual meeting of stockholders held on May 1, 2025 (the “Annual Meeting”), the Company’s stockholders approved the Amended 2010 Plan.

   Read the 8-K filing
7. Jan 6, 2025

   Effective January 1, 2025, Jamie E. Samath was promoted to serve as Executive Vice President, Chief Financial Officer and Head of Business Technology of Intuitive Surgical, Inc. (the “Company”). Mr. Samath previously served as Senior Vice President, Chief Financial Officer and Head of Business Technology. In connection with Mr. Samath’s promotion, his annual base salary was increased from $605,000 to $683,000, and his target annual cash bonus opportunity (as a percentage of base salary) was increased from 65% to 100%. In addition, effective January 1, 2025, Henry L. Charlton was promoted to serve as Executive Vice President, Chief Commercial and Marketing Officer of the Company. Mr. Charlton previously served as Senior Vice President, Chief Commercial and Marketing Officer. In connection with Mr.

   Read the 8-K filing
8. Jul 25, 2024

   (d) On July 24, 2024, the Board of Directors (the “Board”) of Intuitive Surgical, Inc. (the “Company”) appointed David J. Rosa to the Board effective as of July 24, 2024. The Board also increased the authorized number of members of the Board to 12, effective as of July 24, 2024. There are no transactions in which Mr. Rosa had or will have a direct or indirect material interest that would be required to be reported under Item 404(a) of Regulation S-K.

   Read the 8-K filing
9. Apr 30, 2024

   On April 25, 2024, the Board of Directors (the “Board”) appointed Lewis Chew to succeed Mark J. Rubash as Chair of the Audit Committee. This appointment took effect on April 25, 2024, in conjunction with Mr. Chew’s election to the Board at the 2024 Annual Meeting of Stockholders (the “Annual Meeting”). Mr. Rubash will continue to serve as a member of the Audit Committee. In addition, the Board appointed Jami Dover Nachtsheim to succeed Alan J. Levy, Ph.D., who did not stand for re-election at the Annual Meeting, as Chair of the Governance and Nominating Committee, effective April 25, 2024.

   Read the 8-K filing
10. Oct 31, 2023

    (d) On October 26, 2023, the Board of Directors (the “Board”) of Intuitive Surgical, Inc. (the “Company”) appointed Sreelakshmi Kolli to the Board effective as of October 27, 2023. The Board also increased the authorized number of members of the Board to 12, effective as of October 27, 2023. Pursuant to the Company’s compensation program for its non-employee directors, Ms. Kolli will receive an annual cash retainer of $70,000 for service as a member of the Board, which amount will be prorated for her service through the next annual meeting of stockholders. On November 10, 2023, Ms. Kolli will receive, pursuant to the Company’s Amended and Restated 2010 Incentive Award Plan, initial grants of an option to purchase shares of the Company’s common stock with a value of $70,000 (“Target Stock Option Value”) and restricted stock units (“RSUs”) with a value of $70,000 (“Target RSU Value”).

    Read the 8-K filing
11. May 16, 2023

    On May 15, 2023, the Board of Directors of Intuitive Surgical, Inc. (the “Company” or “Intuitive”) promoted David J. Rosa to the role of President of the Company, effective May 16, 2023. In connection with Mr. Rosa’s promotion, Gary S. Guthart, Ph.D., will cease to hold the title of President and will continue to serve as the Company’s Chief Executive Officer and as a member of its Board of Directors. Mr. Rosa will continue to report directly to Dr. Guthart. David J. Rosa, age 55, joined Intuitive in March 1996 and has held leadership positions across the organization in commercial, engineering, clinical development, marketing, and product development. In April 2011, Mr. Rosa was promoted to the position of Senior Vice President, Emerging Procedures & Technology, and transitioned to the position of Senior Vice President, Scientific Affairs. In August 2014, Mr.

    Read the 8-K filing
12. May 3, 2022

    Approval of the Amendment and Restatement of the Amended and Restated 2010 Incentive Award Plan The Board of Directors (the “Board”) of Intuitive Surgical, Inc. (the “Company”) previously adopted, subject to stockholder approval, the amendment and restatement of the Company’s Amended and Restated 2010 Incentive Award Plan (the “Amended 2010 Plan”), which (i) increases the number of shares of common stock reserved for issuance pursuant to awards granted under the Amended 2010 Plan from 103,350,000 to 110,350,000, and (ii) extends the term of the Amended 2010 Plan to 2032. At the Company’s annual meeting of stockholders held on April 28, 2022 (the “Annual Meeting”), the Company’s stockholders approved the Amended 2010 Plan.

    Read the 8-K filing
13. Oct 19, 2021

    Appointment of Certain Officers. In connection with executive leadership changes announced on October 19, 2021, Intuitive Surgical, Inc. (the “Company”) appointed Jamie Samath as Chief Financial Officer, effective as of January 1, 2022. Mr. Samath, age 51, joined Intuitive as Vice President, Corporate Controller in April 2013 and was promoted to Senior Vice President, Finance in July 2019. Prior to joining Intuitive, Mr. Samath was Vice President, Finance, Corporate Controller at Atmel Corporation and, before that, was Vice President, Finance, Corporate Controller at National Semiconductor Corporation. Mr. Samath is a graduate of London Metropolitan University where he earned a B.A. in Business Studies. In addition, Fredrik Widman will serve as the Company’s Principal Accounting Officer, effective January 1, 2022. Mr.

    Read the 8-K filing
14. Apr 26, 2021

    Approval of the Amendment and Restatement of the Amended and Restated 2010 Incentive Award Plan The Board of Directors (the “Board”) of Intuitive Surgical, Inc. (the “Company”) previously adopted, subject to stockholder approval, the amendment and restatement of the Company’s Amended and Restated 2010 Incentive Award Plan (the “Amended 2010 Plan”), which (i) increases the number of shares of common stock reserved for issuance pursuant to awards granted under the Amended 2010 Plan from 32,450,000 to 34,450,000, (ii) extends the term of the Amended 2010 Plan to 2031 and (iii) provides that dividends and dividend equivalents may only be paid to the extent the underlying award vests, and (iv) includes certain changes to further reflect the elimination of the “qualified performance-based compensation” exemption from the tax deduction limits imposed by Section 162(m) of the Internal Revenue Co…

    Read the 8-K filing
15. Apr 28, 2020

    Approval of the Amendment and Restatement of the Amended and Restated 2010 Incentive Award Plan The Board of Directors (the “Board”) of Intuitive Surgical, Inc. (the “Company”) previously adopted, subject to stockholder approval, the amendment and restatement of the Company’s Amended and Restated 2010 Incentive Award Plan (the “Amended 2010 Plan”), which (i) increases the number of shares of common stock reserved for issuance pursuant to awards granted under the Amended 2010 Plan from 28,450,000 to 32,450,000, (ii) extends the term of the Amended 2010 Plan to 2030 and (iii) includes certain changes to reflect the elimination of the “qualified performance-based compensation” exemption from the tax deduction limits imposed by Section 162(m) of the Internal Revenue Code.

    Read the 8-K filing

Proxy statements (DEF 14A): 2026 · 2025 · 2024 · 2023 · 2022 · 2021

From the company's 10-K XBRL data (SEC companyfacts).

People who stopped filing as an insider of this company. “Last filing” is the last Form 3/4/5, an upper bound on when they left.